ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC15379-10mg |
|
1193383-09-3 |
JNJ-42041935
|
0 | C12H6ClF3N4O3 | |
GC15379-5mg |
|
1193383-09-3 |
JNJ-42041935
|
0 | C12H6ClF3N4O3 | |
GC15379-1mg |
|
1193383-09-3 |
JNJ-42041935
|
0 | C12H6ClF3N4O3 | |
GC15378-100g |
|
90-44-8 |
Anthrone
|
0 | C14H10O | |
GC15378-25g |
|
90-44-8 |
Anthrone
|
0 | C14H10O | |
GC15377-50mg |
|
1374639-75-4 |
LEE011 succinate
|
0 | C27H36N8O5 | |
GC15377-25mg |
|
1374639-75-4 |
LEE011 succinate
|
0 | C27H36N8O5 | |
GC15377-10mg |
|
1374639-75-4 |
LEE011 succinate
|
0 | C27H36N8O5 | |
GC15377-5mg |
|
1374639-75-4 |
LEE011 succinate
|
0 | C27H36N8O5 | |
GC15376-1mg |
|
1315378-77-8 |
Rac1 Inhibitor F56, control peptide
|
0 | C72H116N18O23S | |
GC15375-10mg |
|
1403764-72-6 |
PFI-1 (PF-6405761)
|
0 | C16H17N3O4S | |
GC15375-50mg |
|
1403764-72-6 |
PFI-1 (PF-6405761)
|
0 | C16H17N3O4S | |
GC15374-50mg |
|
138356-21-5 |
BD 1047 dihydrobromide
|
0 | C13H20Cl2N2.2HBr | |
GC15374-10mg |
|
138356-21-5 |
BD 1047 dihydrobromide
|
0 | C13H20Cl2N2.2HBr | |
GC15373-10mM (in 1mL DMSO) |
|
334-49-6 |
(E)-2-Decenoic acid
|
0 | C10H18O2 | |
GC15373-25mg |
|
334-49-6 |
(E)-2-Decenoic acid
|
0 | C10H18O2 | |
GC15372-100mg |
|
183718-75-4 |
N-(3-hydroxyphenyl)-Arachidonoyl amide
|
0 | C26H37NO2 | |
GC15372-50mg |
|
183718-75-4 |
N-(3-hydroxyphenyl)-Arachidonoyl amide
|
0 | C26H37NO2 | |
GC15372-10mg |
|
183718-75-4 |
N-(3-hydroxyphenyl)-Arachidonoyl amide
|
0 | C26H37NO2 | |
GC15372-5mg |
|
183718-75-4 |
N-(3-hydroxyphenyl)-Arachidonoyl amide
|
0 | C26H37NO2 | |